This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of BRIVIACT 100 MG TABLET 60S, a pharmaceutical product, with a ceiling value of $5,410.70 and a period of performance through December 27, 2024. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999 through November 2026, which serves as the primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This specific delivery order contract does not have a set-aside designation, indicating open competition. The contract supports the DLA's mission to provide medical commodities to military treatment facilities, veterans' healthcare programs, and other federal medical institutions.
Generated 3/27/25, 9:54 AM